Seeking Alpha
Profile|
( followers)

Rob Zenilman submits: Normalized net profit margins in the Biotech sector for the most recently reported quarter ranged from 41.4% (NASDAQ:GILD) down to -182.6% (NASDAQ:INCY), with a median value of 5.0%

Note: Normalized net income includes the effect of taxes, but excludes any unusual items.

* View More Biotech Sector Charts *

Data in table version -- click on a ticker for opinion and analysis of the company:

Total Norm. Net Norm. Net
Quarter Revenue Profit Profit
Ticker Company Ending ($mm) ($mm) Margin (%)
AFFXAffymetrix Inc.03/31/06$86.39$4.35
5.0%
ALXNAlexion Pharmaceutic03/31/06$0.77-$17.07
N/A
AMGNAmgen Inc.03/31/06$3217.00$896.00
27.9%
AMLNAmylin Pharmaceutica03/31/06$82.35-$31.56
-38.3%
BIIBBiogen Idec Inc.03/31/06$427.80$158.60
37.1%
BMRNBioMarin Pharmaceuti03/31/06$13.81-$4.10
-29.7%
BSTEBiosite Incorporated03/31/06$79.33$18.44
23.2%
CELGCelgene Corporation03/31/06$181.84$36.24
19.9%
DNAGenentech Inc.03/31/06$1986.00$504.00
25.4%
ELNElan Corp. plc03/31/06$134.30-$36.36
-27.1%
GILDGilead Sciences Inc.03/31/06$692.88$286.62
41.4%
GPROGen-Probe Inc.03/31/06$86.26$19.08
22.1%
IMCLImclone Systems Inc.03/31/06$245.13$95.20
38.8%
INCYIncyte Corp.03/31/06$6.47-$11.80
-182.6%
ISTAISTA Pharmaceuticals03/31/06$5.55-$6.09
-109.8%
KOSPKOS Pharmaceuticals 03/31/06$170.77$7.91
4.6%
MEDIMedImmune Inc.03/31/06$498.00$68.64
13.8%
NABINabi Biopharmaceutic04/01/06$27.55-$11.30
-41.0%
NBIXNeurocrine Bioscienc03/31/06$19.48-$9.39
-48.2%
ONXXOnyx Pharmaceuticals03/31/06N/A-$9.09
N/A
PGNXProgenics Pharmaceut03/31/06$11.00$0.55
5.0%
PHRMPharmion Corp.03/31/06$56.59$2.62
4.6%
TELKTelik Inc.03/31/06N/A-$8.92
N/A
VRTXVertex Pharmaceutica03/31/06$39.09-$23.35
-59.7%

Data: CapitalIQ

Related:

  1. Most recent opinion and analysis of Biotech stocks
  2. Full transcripts of recent conference calls in the Biotech sector
  3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?

Source: Chart: Biotech Stocks - Normalized Net Profit Margins